A. Unal Et Al. , "Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)," EUROPEAN JOURNAL OF CANCER , vol.35, 1999
Unal, A. Et Al. 1999. Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS). EUROPEAN JOURNAL OF CANCER , vol.35 .
Unal, A., Cetin, M., & Eser, B., (1999). Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS). EUROPEAN JOURNAL OF CANCER , vol.35.
Unal, A, MUSTAFA ÇETİN, And B Eser. "Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)," EUROPEAN JOURNAL OF CANCER , vol.35, 1999
Unal, A Et Al. "Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)." EUROPEAN JOURNAL OF CANCER , vol.35, 1999
Unal, A. Cetin, M. And Eser, B. (1999) . "Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)." EUROPEAN JOURNAL OF CANCER , vol.35.
@article{article, author={A Unal Et Al. }, title={Low dose Idarubicine, Vincristin, Prednisone, and G-CSF plus ATRA for the treatment of poor risk myelodysplastic syndrome (MDS)}, journal={EUROPEAN JOURNAL OF CANCER}, year=1999}